Stockreport

Praxis Precision Medicines Inc (PRAX) Q3 2024 Earnings Call Highlights: Strong Cash Position ... [Yahoo! Finance]

Praxis Precision Medicines, Inc.  (PRAX) 
PDF General and Administrative (G&A) Expenses: $15.3 million in Q3 2024. Operating Cash Spend: $27.7 million in Q3 2024. Cash, Cash Equivalents, and Marketable Securiti [Read more]